Reduction in driveline infection rates: Results from the HeartMate II Multicenter Driveline Silicone Skin Interface (SSI) Registry

被引:53
作者
Dean, David [1 ]
Kallel, Faouzi [2 ]
Ewald, Gregory A. [3 ]
Tatooles, Antony [4 ]
Sheridan, Brett C. [5 ]
Brewer, Robert J. [6 ]
Caldeira, Christian [7 ]
Farrar, David J. [2 ]
Akhter, Shahab A. [8 ]
机构
[1] Piedmont Healthcare, Atlanta, GA 30309 USA
[2] Thoratec Corp, Pleasanton, CA USA
[3] Washington Univ, Sch Med, St Louis, MO USA
[4] Advocate Christ Hosp Med Ctr, Oak Lawn, IL USA
[5] Univ N Carolina, Chapel Hill, NC USA
[6] Henry Ford Hosp, Detroit, MI 48202 USA
[7] Tampa Gen Hosp, Tampa, FL 33606 USA
[8] Univ Wisconsin, Madison, WI USA
关键词
MCS; VAD; HeartMate II; driveline infection; heart failure; VENTRICULAR ASSIST DEVICE; CIRCULATORY SUPPORT; TRANSPLANTATION; OUTCOMES;
D O I
10.1016/j.healun.2014.11.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: During left ventricular assist device implantation, a surgical tunneling technique to keep the entire driveline (DL) velour portion in the subcutaneous tunnel, resulting in a silicone-skin interface (SSI) at the exit site, has been adopted by many centers. To assess long-term freedom from DL infection associated with this technique, a multicenter SSI registry was initiated. It was hypothesized that the modified tunneling technique is associated with at least 50% reduction in DL infection at 1 year post-implant compared with the velour-to-skin method used in the HeartMate II (HMI) Destination Therapy (DT) trial. METHODS: SSI is a retrospective and prospective registry of patients who have received the HMII device. Results are reported from the retrospective cohort, which consists of 200 patients who were implanted during the period 2009-2012 with the SSI tunneling method and on HMII support for at least 10 months at the time of enrollment. The prevalence and incidence of DL infection after left ventricular assist device implantation in the SSI retrospective cohort were determined and compared with a control group of 201 patients also on HMII support for at least 10 months from the HMI DT clinical trial who were implanted during the period 2007-2009 using the traditional method in which a small section of the velour portion of the DL was extemalind. RESULTS: The 1-year and 2-year prevalence rates of DL infection were 9% and 19% in the SSI patient group compared with 23% and 35% in the control group (hazard ratio 0.49, 95% confidence interval 0.33-0.73, p < 0.001). The event-per-patient year was 0.11 and 0.22 for the SSI and control groups, respectively (p < 0.001). Based on a multivariate analysis, age and DL exit side were the only independent variables associated with DL infection. Effects of management changes over the eras were not studied and could have contributed to the findings. CONCLUSIONS: These results suggest that leaving the entire DL velour portion below the skin is associated with 50% reduction in DL infection compared with results from the HMI( DT trial. I Heart Lung Transplant 2015;34:781-789 (C) 2015 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:781 / 789
页数:9
相关论文
共 13 条
[1]  
Akhter S, 2012, INT SOC HEART LUNG T
[2]  
Akhter S, 2011, INT SOC HEART LUNG T
[3]   Continuous-flow devices and percutaneous site infections: Clinical outcomes [J].
Goldstein, Daniel J. ;
Naftel, David ;
Holman, William ;
Bellumkonda, Lavanya ;
Pamboukian, Salpy V. ;
Pagani, Francis D. ;
Kirklin, James .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (11) :1151-1157
[4]   Prospective, Multicenter Study of Ventricular Assist Device Infections [J].
Gordon, Rachel J. ;
Weinberg, Alan D. ;
Pagani, Francis D. ;
Slaughter, Mark S. ;
Pappas, Pat S. ;
Naka, Yoshifumi ;
Goldstein, Daniel J. ;
Dembitsky, Walter P. ;
Giacalone, Julie C. ;
Ferrante, Jennifer ;
Ascheim, Deborah D. ;
Moskowitz, Alan J. ;
Rose, Eric A. ;
Gelijns, Annetine C. ;
Lowy, Franklin D. .
CIRCULATION, 2013, 127 (06) :691-+
[5]   Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients [J].
Kirklin, James K. ;
Naftel, David C. ;
Kormos, Robert L. ;
Stevenson, Lynne W. ;
Pagani, Francis D. ;
Miller, Marissa A. ;
Baldwin, J. Timothy ;
Young, James B. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (02) :141-156
[6]  
Ledford ID, 2011, INT SOC HEART LUNG T
[7]   Use of a continuous-flow device in patients awaiting heart transplantation [J].
Miller, Leslie W. ;
Pagani, Francis D. ;
Russell, Stuart D. ;
John, Ranjit ;
Boyle, Andrew J. ;
Aaronson, Keith D. ;
Conte, John V. ;
Naka, Yoshifumi ;
Mancini, Donna ;
Delgado, Reynolds M. ;
MacGillivray, Thomas E. ;
Farrar, David J. ;
Frazier, O. H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (09) :885-896
[8]   Outcomes in Advanced Heart Failure Patients With Left Ventricular Assist Devices for Destination Therapy [J].
Park, Soon J. ;
Milano, Carmelo A. ;
Tatooles, Antone J. ;
Rogers, Joseph G. ;
Adamson, Robert M. ;
Steidley, D. Eric ;
Ewald, Gregory A. ;
Sundareswaran, Kartik S. ;
Farrar, David J. ;
Slaughter, Mark S. .
CIRCULATION-HEART FAILURE, 2012, 5 (02) :241-248
[9]  
Pelz GB, 2010, INT SOC HEART LUNG T
[10]   Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device [J].
Slaughter, Mark S. ;
Rogers, Joseph G. ;
Milano, Carmelo A. ;
Russell, Stuart D. ;
Conte, John V. ;
Feldman, David ;
Sun, Benjamin ;
Tatooles, Antone J. ;
Delgado, Reynolds M., III ;
Long, James W. ;
Wozniak, Thomas C. ;
Ghumman, Waqas ;
Farrar, David J. ;
Frazier, O. Howard .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (23) :2241-2251